<?xml version="1.0" encoding="UTF-8"?>
<codeBook>
      <docDscr>
         <citation>
            <titlStmt>
               <titl>Effects of Maternal IBD and IBD Breast Milk on Neonatal Gut Microbiome and Intestinal Inflammation</titl>
            </titlStmt>
         </citation>
      </docDscr>
      <stdyDscr>
         <citation>
            <titlStmt>
               <titl>Effects of Maternal IBD and IBD Breast Milk on Neonatal Gut Microbiome and Intestinal Inflammation</titl>
            </titlStmt>
            <rspStmt>
               <AuthEnty affiliation="University of Alberta">Huang, Vivian</AuthEnty>
               <AuthEnty affiliation="University of Alberta">Madsen, Karen</AuthEnty>
               <AuthEnty affiliation="University of Alberta">Fedorak, Richard</AuthEnty>
               <AuthEnty affiliation="University of Alberta">Elahi, Shokrollah</AuthEnty>
               <AuthEnty affiliation="University of Alberta">Dieleman, Levinus</AuthEnty>
               <AuthEnty affiliation="University of Alberta">Wine, Eytan</AuthEnty>
               <AuthEnty affiliation="University of Alberta">Agrawal, Ambika</AuthEnty>
            </rspStmt>
            <prodStmt>
               <producer affiliation="University of Alberta">Preconception and Pregnancy in Inflammatory Bowel Disease Clinical Research Program<ExtLink URI="http://pregnancy.ibdclinic.ca/"/>
               </producer>
               <prodDate>2015</prodDate>
               <prodPlac>Edmonton, Alberta</prodPlac>
               <grantNo agency="Future Leaders in IBD (FLIBD)"/>
               <software>Microsoft Excel</software>
               <software version="23">SPSS</software>
            </prodStmt>
            <distStmt>
               <contact affiliation="University of Alberta" email="pregibd@ualberta.ca">Huang, Vivian</contact>
            </distStmt>
            <serStmt/>
         </citation>
         <dataAccs>
            <useStmt>
               <restrctn>Author determines access on a case-by-case basis</restrctn>
               <restrctn>Data-sharing agreement, including undertaking of confidentiality</restrctn>
               <conditions>Access is permitted for external researchers, with limitations</conditions>
               <restrctn>Access only for REB-approved projects</restrctn>
               <conditions>Access to deidentified data may be permitted for external researchers, with limitations. Only researchers with REB-approved projects may be permitted access to the deidentified data. A basic data sharing agreement form is required (ie. Agree to not attempt to re-identify the records so as to relate the information on the file to a particular person). The data producer determines access on a case-by-case basis. Contact the data producer directly to discuss terms and conditions of access.</conditions>
            </useStmt>
            <setAvail>
               <accsPlac>CEGIIR (Centre of Excellence for Gastrointestinal Inflammation and Immunity Research) www.cegiir.med.ualberta.ca</accsPlac>
               <avlStatus>Not yet available: Data may be unavailable because it is still being collected,
            because it is embargoed for a period of time, because it has been superseded,
            etc.</avlStatus>
            </setAvail>
         </dataAccs>
         <stdyInfo>
            <abstract>The objective of the study is to compare the intestinal inflammatory response markers of infants born to healthy mothers versus IBD mothers. As well, the fecal microbiome of infants who are breast fed by healthy mothers versus IBD mothers, and  the immunoactive components of breast milk from healthy mothers versus IBD mothers, will be compared.</abstract>
            <subject>
               <keyword vocab="MeSH">Crohn's disease</keyword>
               <keyword vocab="MeSH">pregnancy</keyword>
               <keyword vocab="MeSH">ulcerative colitis</keyword>
               <keyword vocab="MeSH">cohort studies</keyword>
               <keyword vocab="MeSH">infant</keyword>
               <keyword vocab="MeSH">breast milk</keyword>
               <keyword vocab="MeSH">microbiota</keyword>
               <keyword vocab="MeSH">immunology</keyword>
               <keyword vocab="MeSH">inflammatory bowel diseases</keyword>
               <keyword vocab="MeSH">breast feeding</keyword>
            </subject>
            <sumDscr>
               <nation>Canada</nation>
               <geogCover>Alberta, Edmonton, Preconception and Pregnancy in Inflammatory Bowel Disease Clinic</geogCover>
               <timePrd event="start">2015</timePrd>
               <timePrd event="end">2017</timePrd>
               <collDate event="start">6/1/2015</collDate>
               <collDate event="end">2017</collDate>
               <anlyUnit>Maternal/infant child dyad</anlyUnit>
               <universe>Mother/infant pairs with mothers with IBD (cases) and healthy mothers (controls) and their infants.</universe>
               <dataKind>Biosamples</dataKind>
               <dataKind>Clinical data</dataKind>
               <dataKind>Questionnaire data</dataKind>
            </sumDscr>
         </stdyInfo>
         <method>
            <dataColl>
               <sampProc>The target number of study participants is 60.</sampProc>
               <frequenc>Data was collected within 48 hours of delivery and at 3 months, 6 months, and 12 months post-delivery.</frequenc>
               <collMode>Self-administered questionnaire: Paper</collMode>
               <collMode>Physical measurements and tests</collMode>
               <collSitu>Maternal breast milk and infant stool samples were collected at each time point. Stool was analysed for microbiome (diversity, communities), sIgA, FCP, cytokine levels. Breast milk was analysed for microbiome, sIgA, calprotectin, cytokines, protein and fat content, (oligosaccharides), in vitro functional studies on colonic cells. Questionnaires include questions about the mother's medication, nutritional supplementation, and questions about infant diet, developmental milestones, etc.</collSitu>
            </dataColl>
         </method>
         <othrStdyMat>
            <relStdy>Immunological Profiling; Elevated Fecal Calprotectin in the Second or Third Trimester of Pregnancy Predicts Preterm Delivery in Women with IBD</relStdy>
         </othrStdyMat>
      </stdyDscr>
   </codeBook>
